Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porterโs Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
6. GLOBAL LYMPHEDEMA TREATMENT MARKET, BY TYPE
6.1. Overview
6.2. Primary Lymphedema
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3. Secondary Lymphedema
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7. GLOBAL LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA
7.1. Overview
7.2. Lower Extremity
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3. Upper Extremity
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4. Genitalia
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8. GLOBAL LYMPHEDEMA TREATMENT MARKET, BY TREATMENT
8.1. Overview
8.2. Compression Devices & Bandages
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3. Laser Therapy
Market Estimates & Forecast, by Country, 2020-2027
Market Estimates & Forecast, by Region, 2020-2027
8.4. Drug Therapy
Market Estimates & Forecast, by Country, 2020-2027
Market Estimates & Forecast, by Region, 2020-2027
8.5. Surgery
Market Estimates & Forecast, by Country, 2020-2027
Market Estimates & Forecast, by Region, 2020-2027
8.6. Others
Market Estimates & Forecast, by Country, 2020-2027
Market Estimates & Forecast, by Region, 2020-2027
9. GLOBAL LYMPHEDEMA TREATMENT MARKET, BY END USER
9.1. Overview
9.2. Hospitals and Clinics
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.3. Clinical Research Organizations
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.4. Research & Academic Institutes
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
10. GLOBAL LYMPHEDEMA TREATMENT MARKET, BY REGION
10.1. Overview
10.2. Americas
10.2.1. North America
10.2.1.1. US
10.2.1.2. Canada
10.2.2. Latin America
10.3. Europe
10.3.1. Western Europe
10.3.1.1. Germany
10.3.1.2. France
10.3.1.3. Italy
10.3.1.4. Spain
10.3.1.5. UK
10.3.1.6. Rest of Western Europe
10.3.2. Eastern Europe
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle East & Africa
10.5.1. Middle East
10.5.2. Africa
11. COMPANY LANDSCAPE
11.1.1. Overview
11.1.2. Competitive Analysis
12. COMPANY PROFILES
12.1. 3A Health Care (Italy)
12.1.1. Company Overview
12.1.2. Type Overview
12.1.3. Financial Overview
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Bio Compression Systems, Inc. (US)
12.2.1. Company Overview
12.2.2. Type Overview
12.2.3. Financial Overview
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Devon Medical Products (US)
12.3.1. Company Overview
12.3.2. Type Overview
12.3.3. Financial Overview
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. HERANTIS PHARMA PLC (Finland)
12.4.1. Company Overview
12.4.2. Type Overview
12.4.3. Financial Overview
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Lohmann & Rauscher (Germany)
12.5.1. Company Overview
12.5.2. Type Overview
12.5.3. Financial Overview
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Mego Afek Ltd (US)
12.6.1. Company Overview
12.6.2. Type Overview
12.6.3. Financial Overview
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. SIGVARIS (Switzerland)
12.7.1. Company Overview
12.7.2. Type Overview
12.7.3. Financial Overview
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Tactile Systems Technology Inc. (US)
12.8.1. Company Overview
12.8.2. Type Overview
12.8.3. Financial Overview
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Wright Therapy Products (BSN Medical) (Germany)
12.9.1. Company Overview
12.9.2. Type Overview
12.9.3. Financial Overview
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Others
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL LYMPHEDEMA TREATMENT MARKET SYNOPSIS, 2020-2027
TABLE 2 GLOBAL LYMPHEDEMA TREATMENT MARKET ESTIMATES & FORECAST, 2020-2027(USD MILLION)
TABLE 3 GLOBAL LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2020-2027(USD MILLION)
TABLE 4 GLOBAL LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2020-2027(USD MILLION)
TABLE 5 GLOBAL LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2020-2027(USD MILLION)
TABLE 6 GLOBAL LYMPHEDEMA TREATMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 7 GLOBAL LYMPHEDEMA TREATMENT MARKET, BY REGION, 2020-2027(USD MILLION)
TABLE 8 NORTH AMERICA: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2020-2027(USD MILLION)
TABLE 9 NORTH AMERICA: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2020-2027(USD MILLION)
TABLE 10 NORTH AMERICA: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2020-2027(USD MILLION)
TABLE 11 NORTH AMERICA: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 12 US: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2020-2027(USD MILLION)
TABLE 13 US: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2020-2027(USD MILLION)
TABLE 14 US: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2020-2027(USD MILLION)
TABLE 15 US: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 16 CANADA: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2020-2027(USD MILLION)
TABLE 17 CANADA: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2020-2027(USD MILLION)
TABLE 18 CANADA: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2020-2027(USD MILLION)
TABLE 19 CANADA: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 20 LATIN AMERICA: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2020-2027(USD MILLION)
TABLE 21 LATIN AMERICA: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2020-2027(USD MILLION)
TABLE 22 LATIN AMERICA: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2020-2027(USD MILLION)
TABLE 23 LATIN AMERICA: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 24 EUROPE: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2020-2027(USD MILLION)
TABLE 25 EUROPE: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2020-2027(USD MILLION)
TABLE 26 EUROPE: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2020-2027(USD MILLION)
TABLE 27 EUROPE: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 28 WESTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2020-2027(USD MILLION)
TABLE 29 WESTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2020-2027(USD MILLION)
TABLE 30 WESTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY TREATMENTT, 2020-2027(USD MILLION)
TABLE 31 WESTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 32 EASTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2020-2027(USD MILLION)
TABLE 33 EASTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2020-2027(USD MILLION)
TABLE 34 EASTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2020-2027(USD MILLION)
TABLE 35 EASTERN EUROPE: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 36 ASIA-PACIFIC: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2020-2027(USD MILLION)
TABLE 37 ASIA-PACIFIC: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2020-2027(USD MILLION)
TABLE 38 ASIA-PACIFIC: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2020-2027(USD MILLION)
TABLE 39 ASIA-PACIFIC: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2020-2027(USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA: LYMPHEDEMA TREATMENT MARKET, BY TYPE, 2020-2027(USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA: LYMPHEDEMA TREATMENT MARKET, BY AFFECTED AREA, 2020-2027(USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA: LYMPHEDEMA TREATMENT MARKET, BY TREATMENT, 2020-2027(USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA: LYMPHEDEMA TREATMENT MARKET, BY END USER, 2020-2027(USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL LYMPHEDEMA TREATMENT MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL LYMPHEDEMA TREATMENT MARKET
FIGURE 4 GLOBAL LYMPHEDEMA TREATMENT MARKET SHARE, BY TYPE, 2020 (%)
FIGURE 5 GLOBAL LYMPHEDEMA TREATMENT MARKET SHARE, BY AFFECTED AREA, 2020 (%)
FIGURE 6 GLOBAL LYMPHEDEMA TREATMENT MARKET SHARE, BY TREATMENT, 2020 (%)
FIGURE 7 GLOBAL LYMPHEDEMA TREATMENT MARKET SHARE, BY END USER, 2020 (%)
FIGURE 8 GLOBAL LYMPHEDEMA TREATMENT MARKET SHARE, BY REGION, 2020 (%)
FIGURE 7 AMERICAS: LYMPHEDEMA TREATMENT MARKET SHARE BY REGION, 2020 (%)
FIGURE 9 NORTH AMERICA: LYMPHEDEMA TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 10 EUROPE: LYMPHEDEMA TREATMENT MARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 WESTERN EUROPE: LYMPHEDEMA TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 12 ASIA-PACIFIC: LYMPHEDEMA TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 13 MIDDLE EAST & AFRICA: LYMPHEDEMA TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 14 GLOBAL LYMPHEDEMA TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 15 3A HEALTH CARE: KEY FINANCIALS
FIGURE 16 3A HEALTH CARE: SEGMENTAL REVENUE
FIGURE 17 3A HEALTH CARE: REGIONAL REVENUE
FIGURE 18 BIO COMPRESSION SYSTEMS, INC.: KEY FINANCIALS
FIGURE 19 BIO COMPRESSION SYSTEMS, INC.: SEGMENTAL REVENUE
FIGURE 20 BIO COMPRESSION SYSTEMS, INC.: REGIONAL REVENUE
FIGURE 21 DEVON MEDICAL PRODUCTS: KEY FINANCIALS
FIGURE 22 DEVON MEDICAL PRODUCTS: SEGMENTAL REVENUE
FIGURE 23 DEVON MEDICAL PRODUCTS: REGIONAL REVENUE
FIGURE 24 HERANTIS PHARMA PLC: KEY FINANCIALS
FIGURE 25 HERANTIS PHARMA PLC: SEGMENTAL REVENUE
FIGURE 26 HERANTIS PHARMA PLC: REGIONAL REVENUE
FIGURE 27 LOHMANN & RAUSCHER: KEY FINANCIALS
FIGURE 28 LOHMANN & RAUSCHER: SEGMENTAL REVENUE
FIGURE 29 LOHMANN & RAUSCHER: REGIONAL REVENUE
FIGURE 30 MEGO AFEK LTD: KEY FINANCIALS
FIGURE 31 MEGO AFEK LTD: SEGMENTAL REVENUE
FIGURE 32 MEGO AFEK LTD: REGIONAL REVENUE
FIGURE 33 SIGVARIS: KEY FINANCIALS
FIGURE 34 SIGVARIS: SEGMENTAL REVENUE
FIGURE 35 SIGVARIS: REGIONAL REVENUE
FIGURE 36 TACTILE SYSTEMS TECHNOLOGY INC.: KEY FINANCIALS
FIGURE 37 TACTILE SYSTEMS TECHNOLOGY INC.: SEGMENTAL REVENUE
FIGURE 38 TACTILE SYSTEMS TECHNOLOGY INC.: REGIONAL REVENUE
FIGURE 39 WRIGHT THERAPY PRODUCTS (BSN MEDICAL): KEY FINANCIALS
FIGURE 40 WRIGHT THERAPY PRODUCTS (BSN MEDICAL): SEGMENTAL REVENUE
FIGURE 41 WRIGHT THERAPY PRODUCTS (BSN MEDICAL): REGIONAL REVENUE